Jim Simons's position in Candel Therapeutics is currently worth $654 Thousand. That's 0.00% of their equity portfolio (2540th largest holding). The first Candel Therapeutics trade was made in Q1 2023. Since then Jim Simons bought shares two more times and sold shares on two occasions. The stake costed the investor $74.9 Thousand, netting the investor a gain of 774% so far.